News - BioPharm International

ADVERTISEMENT

News

Ascension Health Bans Genentech Sales Reps After Losing Drug Discounts

October 7, 2014

A change in the supply chain for three important Genentech cancer medications elicits a strong reaction from one of the nation's largest operators of hospitals.

Salix Looks to Actavis After Terminating Cosmo Deal

October 6, 2014

New rules from the Treasury Department regarding inversion affect merger activity in the pharmaceutical sector.

Jagged Little Pill: Drug Delivery Through the Use of Microneedles

October 3, 2014

Delivery of large protein biopharmaceuticals may now be administered orally with the help of microneedles, according to researchers at MIT.

Hospira's Australian Manufacturing Plant Receives FDA Warning Letter

October 3, 2014

Impurities, particulates, and a lack of communication are among Hospira's recent violations described in a warning letter from FDA.

Making ZMapp: Production of Experimental Drug to Treat Ebola Is Now A Priority

October 2, 2014

Manufacturing drugs from biological sources sometimes can't be rushed, even when a rare disease becomes more widespread.

HydRIS Vaccine Stability Device Could Revolutionize Cold-Chain Requirements

October 2, 2014

Nova Bio-Pharma Technologies' new vaccine stability device eliminates the need for cold storage.

New Tax Rules May Deter Future Pharma M&A

October 1, 2014

Inversions in the pharmaceutical sector could become less lucrative as a result of new tax laws.

New Report Details Players and Pipelines in the Biosimilar Space

September 30, 2014

A new Thomson Reuters BioWorld report outlines the more than 700 biosimilars that are currently in development and the emerging business opportunities that exist in the biopharmaceutical space.

NIH Seeks to Improve Vaccine Response with New Adjuvants

September 30, 2014

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

ADVERTISEMENT

ADVERTISEMENT

Click here